ConV2X — Integrating Emerging Technology in
Healthcare and Life Sciences | Preliminary Agenda
ConV2X Day 1
https://conv2xsymposium.com/registration/
September 10, 2024–10 AM — 9 PM ET
9:50 AM | Welcome Address and Introductions Tory Cenaj, Founder and CEO, Partners in Digital Health, Blockchain in Healthcare Today Platform Approaches Journal (BHTY)
10:00 AM — 10:30 AM | Featured Keynote — The Deliberate Habits of a Bold Risk Taker Daniel Seewald, Founder & CEO, Deliberate Innovation, and Former Pfizer Head of Worldwide Innovation
Risk taking is at the very core of experimenting and embracing new and
emergency technologies. The interactive keynote by thought leader will
include:
∙ The importance of bold risk taking when it comes to new tech
∙ What stops us from taking bold risks with emerging tech
∙ Three (3) deliberate practices to be more bold
∙ a practical exercise to create your very own boldness action plan
10:30 AM — 11:00 AM | Multi-chain network and process certification: new tools for healthcare web3 applications Gianluca de Novi, PhD, CEO, Circular Labs
11:00 AM — 11:30 AM | COMPASS: A Cross-Institutional Cancer Network Powering Precision Medicine Throughout the Patient Journey Yuri Quintana, Chief, Division of Clinical Informatics (DCI), BIDMC
The presentation will showcase the DCI Network’s groundbreaking Cancer COMPASS initiative, a comprehensive data integration platform designed to revolutionize cancer care across the entire patient journey. We will discuss how COMPASS will connect patient data from screening and diagnosis through treatment and remote follow-up monitoring, creating a continuous, data driven care pathway. We are employing innovative methods to harmonize data from diverse sources, including community hospitals, academic medical centers, and patient-reported outcomes, providing patients and healthcare providers with an unprecedented, holistic view of each case. We will describe the DCI Network collaborative ecosystem we’ve cultivated, bringing together patients, academics, non-profit organizations, private sector companies, and government entities. This multidisciplinary partnership has been crucial in developing agile architectures that support precision medicine and lay the groundwork for advanced AI applications in oncology, ultimately enabling truly patient-centered care and data-informed decision-making across the cancer care continuum.
By attending this talk, you’ll gain insights into the technical challenges and solutions in building a cross-institutional data network and strategies for ensuring data interoperability and patient privacy, the potential of integrated data systems to transform cancer care and research, and how collaborative ecosystems can drive innovation in healthcare technology.
11:30 AM — 12:00 PM | ConV2X Ignition Pitch Competition | Judges: Allison Byers, Erik Bullen, Rama Rao, Manuel Rinaldi, Moderator: Kenneth Goodwin
Lunch: Noon — 12:30 PM
12:30 PM — 1:00 PM | Empowering Patients: The Next Era of Self-Sovereign Identity, Privacy, and Health Data Stewardship in Healthcare Kris Komanduru, CTO, Tivra Health and Dennis Maliani, CEO, Apotheka
In the rapidly evolving landscape of healthcare, the integration of blockchain technology offers transformative potential in managing health data while ensuring privacy and security. This presentation will explore the concept of Self-Sovereign Identity (SSI) and its potential to revolutionize health data management by giving patients full control over their health information. We will discuss how SSI can enhance privacy, reduce risks associated with data breaches, and empower individuals by placing them at the center of their healthcare journey. Experts from health tech, data governance, and privacy will share insights on how SSI enables patients to own, manage, and share their data without relying on centralized entities, thus safeguarding privacy.
1:00 PM — 3:00 PM | AI•XR•Web3 Powered Digital Health Revolution | Session Chair: Alex G. Lee, Founder and CEO, TechIP, LLC
The session will explore the convergence of AI, XR, and Web3 technologies in transforming digital health, and focus on applications, challenges, and future potential in revolutionizing healthcare delivery, financing, and patient engagement. Participants will gain insight into the practical applications and real-world impact of technology, identification of challenges, and collaborative strategies to employ for successful integration of digital health technologies.
Presentations
Rahaf Al Assil, CEO, PantridgeDTell
Raul Uppot, Associate Professor of Radiology, Harvard Medical School/MGH Ki-youn Jung, MBA, CEO, EON Health
Rebecca Miksad, MD, Associate Professor of Medicine, Boston University School of Medicine Guillaume Poirier, PhD, Principal Consultant, NTX Services
Alex G. Lee, PhD, Esq, TechIP, LLC
∙ Convergence of AI, XR, and Web3 for Digital Health
∙ Application of Mixed Reality in Healthcare
∙ Digital Healthcare Platform Strategy as Mainstream Healthcare
∙ Interoperability as Strategy: The Cornerstone of commercializing AI Tools Across ∙ Healthcare Ecosystems
∙ Challenges Developing Digital Health Technology as a VC Friendly Medical Application ∙ Blockchain-Powered Web3 in Healthcare
Discussion I: Challenges and Opportunities with Web3 and Health Behavior Change(s) Ki-youn Jung, MBA, CEO, EON Health
Guillaume Poirier, PhD, Principal Consultant, NTX Services
Rebecca Miksad, MD, Associate Professor of Medicine, Boston University School of Medicine Jennifer Gentile, Founder and Chief Clinical Officer, Thynk Inc, Moderator
Discussion II: Adoption of Digital Health as a Mainstream in Preventive Healthcare — Focus on Cardiology
Jennifer Joe, MD, Senior Director of Global Medical Strategy & Population Health, AstraZeneca Alex G. Lee, PhD, Esq, TechIP, LLC
Mehdi Mortazawy, Co-Founder and CTO, Coredio Corp.
Rahaf Al Assil, CEO, PantridgeDTell, Moderator
3:00 PM — 3:30 PM | IoMT / AI / Blockchain-Based Medical Decision Support David A. Hall MHA, Managing Director, AKT Health Inc.
The presentation will address several key themes and provide practical solutions to current challenges in the industry and include detailed Case Studies of successful implementations of solution in clinical settings. Te presentation will include identifying the current challenges such as legacy systems, high costs, security vulnerabilities, and the need for interoperability. An overview of the market landscape with an analysis of market size and opportunities for RPM, DCT, DTx, IoMT, AI, and blockchain in healthcare will be presented along with architecture of solutions for adverse events, data collection methods, and integration with clinical systems.
∙ Healthcare Transformation Roadmaps
∙ Patient Health Records, Self-sovereign Identity, and Privacy
∙ Interoperability and Public Health
∙ Decentralized Clinical Trials
∙ Digital Twins, AI, Blockchain, and the Cloud
∙ Cyber Network Security and Quantum Safe Cryptography
3:30 PM — 4:00 PM | Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) Eliel Oliveira, MBA, MSc, Sr. Director, Department of Population Medicine, Harvard Pilgrim Health Care Institute
ONC’s HTI-2 implements provisions of the 21st Century Cures Act and reflects ONC’s focused efforts to advance interoperability and improve information sharing among patients, providers, payers, and public health authorities. As part of the ONC Task Force at HITAC, Dr. Oliveira will share reflections and recommendations.
4:00 PM — 4:30 PM | Decentralized AI Roadmap Ramesh Raskar, Associate Director, MIT Media Lab
Be the first to glean insight and guidance for this highly anticipated new roadmap to be unveiled soon!
4:30 PM — 5:00 PM | The Critical Intersection of Company Building and Advocacy Work in the Blockchain Industry and Beyond Alison Byers, CEO, Scroobious and Marquesa Finch, CEO and Partner, Healthcare Silicon Valley Blockchain Society and Pyrium
This panel will delve into how companies are leveraging technology to drive diversity and inclusivity in the startup and investing industries. As co-authors of the groundbreaking California SB54 legislation, signed into law this past year, speakers will discuss the importance of regulatory efforts and share insights on why it’s essential to integrate advocacy into business strategies. Attendees will gain valuable perspectives on the current state of diversity in blockchain and its implications for the healthcare sector. The session will include a dynamic discussion followed by a Q&A segment to engage the audience.
5:00 PM — 5:30 PM | Platform Interoperability: Better Outcomes for Patients in Value Based Care Arun Buduri, VP Engineering and IT, Innovaccer
5:30 PM — 6:00 PM | Your Company has a Technology Platform, but do You have a Platform Business Model and Strategy? Vince Kuraitis, JD, Founder, Better Health Technologies
In healthcare today, platforms are understood mostly as technology. This perspective misses a huge opportunity. Platforms are powerful. Four of the top five companies in the world are platforms. In other industries, platforms can be a business model and strategy. Learn how your technology platform can be turbocharged by understanding the power of platform business models and strategies as we answer questions below.
∙ The “North Star” of a platform business model is achieving network effects — where users experience more value as the size of the network increases. Network effects are the single greatest differentiator in platform success. Major issues to address include:
∙ How to solve the chicken/egg (aka cold start) problem — achieving critical mass on both the supply and demand sides of the platform
∙ What types of network effects are possible?
∙ What’s the relative strength of different types of network effects?
∙ How should the platform be designed?
∙ What’s the optimal monetization approach? Should one side be subsidized? ∙ How open should the platform be?
∙ What’s the optimal governance model?
∙ What are key metrics to measure progress and success?
∙ How can AI or blockchain function “as platforms”?
6:30 PM — 9:00 PM Evening Award and Network Reception | 16C Restaurant | 16 Cottage Ave, Quincy, MA 02169 (Next door to event location)
ConV2X Day 2
September 11, 2024
8:00 AM — 8:30 AM | Managing Supplier Risk in Supply Chain with AI and Blockchain — A TYS Perspective Mohan Venkataraman, CTO, Chainyard
This presentation will explore how a digital transformation advisory firm is addressing critical risks and compliance challenges within the complex supply chain. The pharma supply chain is complex where supplier on boarding and third-party risk management becomes crucial. Using TYS, a groundbreaking platform that leverages blockchain as a foundation for trust, AI and machine learning, learn how to enhance buyer-supplier collaboration and minimize supplier risk.
8:30 AM — 9:00 AM | Decentralized Healthcare: Bridging Technology, Society, and Partnerships for Maximum Impact Hui Huang, PhD, Co-Founder Etheros HealthData Foundation, Former Vice President, Head of Global Value & Access Oncology
Content:
∙ Current state of decentralized healthcare technologies and their applications — what have we learned?
∙ Algo-vision: Reimagining societal impact through health tech innovation — why should we consider both technology and society?
∙ Unlocking hidden value through NGO and Public-Private Partnership — how to strategize your tech innovation to maximize its impact?
Takeaways
∙ Strategies for integrating societal factors to drive market growth and ethical innovation
∙ Harnessing diverse perspectives to create robust, widely adopted health solutions
∙ Opportunities for cross-sector, cross-border collaboration in decentralized healthcare
9:00 AM — 9:45 AM | Featured Keynote — Blockchain, Digital Identity, and Proof-of-Existence: The United Nations Joint Staff Pension Fund’s Experience and Solution Dino Cataldo Dell’Accio, CIO, United Nations Joint Staff Pension Fund and Co-Lead of Dynamic Coalition on Blockchain Assurance & Standardization, GBA
In January 2021, in accordance with its digital transformation strategy, UNJSPF deployed a digital solution based on blockchain, biometrics, artificial intelligence, and geolocalization to transform a legacy process with a global reach (86K beneficiaries located in more than 192 countries). UNJSPF beneficiaries are required to sign and submit a “Certificate” as a “proof of their existence” to continue receiving benefits every year. The UNJSPF award winning digital solution is supported by blockchain, biometrics, artificial intelligence, and geolocation technologies to create, verify, and secure the digital identities of its beneficiaries, prevent fraud, and store identifiers of transactions on an immutable, traceable, and independently auditable ledger, using the Hyperledger Indy platform.
This solution addressed both technical and business requirements, focusing on innovation and technology for social good. Session details include:
∙ Definition of the problem
∙ Approach developed for addressing the problem
∙ Achieved outcome
∙ Assurance criteria
∙ Algorithm Audit & ISO Certification
∙ Technical details on:
∙ Blockchain
∙ Biometrics/Facial recognition
9:45 AM — 10:15 AM | Exploring the Potential of Tokenomics Models in Healthcare Employing Zero Trust Frameworks David Stefanich, CEO, Rymedi
Where can cryptocurrency representations for health information be utilized to incentivize data sharing while maintaining privacy, security, and dynamic access control systems within a ZTA framework. Key aspects to be discussed include:
∙ Authentication and authorization protocols for healthcare & Life Science professionals and patients
∙ Securing bring your own device (BYOD) scenarios in medical settings ∙ Protecting cloud-based healthcare assets and services
∙ Implementing end-to-end security for health data transactions
∙ Ensuring interoperability while maintaining strict security measures
∙ Leveraging blockchain technology for secure, private, multi jurisdictional data exchanges
10:15 AM — 10:45 AM | Bridging the Financial Gaps: Revenue Automation by Enhancing Operational Efficiencies and Financial Tools for CROs and Clinical Sites Rama Rao, CEO, BlocQube and Enrico Perfler, CEO, 1Med CRO, Switzerland
This session delves into the critical financial challenges faced by CROs and sites, including delayed payments, unpredictable cash flows, and the impact of inflation on long-term contracts. Recent insights from the Society for Clinical Research Sites (SCRS) highlight the precarious financial position many sites find themselves in — 26% of sites have a mere six months of financial runway, while 10% are one late payment away from shutting down. Participants will gain valuable insights into the current financial landscape of clinical trials, understand the pressing need for operational efficiency, and learn about innovative solutions that can help bridge the financial gaps faced by sites and CROs. This session is essential for anyone involved in clinical research that is looking to improve financial sustainability and operational effectiveness. Speakers will discuss:
∙ The financial challenges impeding site and CRO performance, with a focus on delayed payments, financial forecasting difficulties, and the impact of inflation.
∙ Discuss the role of operational inefficiencies in exacerbating financial stress, particularly in the context of budget negotiations and Clinical Trial Agreements (CTAs).
∙ Present potential solutions, including how blockchain technology could revolutionize financial management in clinical trials, providing greater transparency, efficiency, and financial stability.
10:45 AM — 11:15 AM | Collaborating to Sustain Success with Transformative Technologies Sathya Krishnasamy, MS, President, Engineering, Emerging Technologies, ChainAim Freddy T. Nguyen, MD, PhD, Fellow and Founder of American Physicians and Scientist Assoc, MIT, Director of the MIT Catalyst Scholars Program, and CEO, Nine Diagnostics Daniel Pietrzykoski, Technical Strategy & Product Innovation — Blockchain & Program Management, J&J
Meredith L. Eaton, Managing Director, North America, RLYL — Moderator
This session will delve into where blockchain has demonstrated — and has the potential to demonstrate — continuous positive outcomes within the healthcare industry. Hear from academic and business leaders on real-world implementations, how partnerships and integrations can foster beneficial relationships for lasting results, and what decision makers need to know for a clear path to adoption.
11:15 AM — 11:45 AM | DLT, AI, And ZK are Coming Together: Barrier Breakers for Mainstream Adoption? Sathya Krishnasamy, MS, President, ChainAim
The author presented the view of the landscape in 2023 in Blockchain in Healthcare adoption. The key points were that blockchain was not just having adoption challenges in Healthcare, but on the whole as a horizontal innovation. See https://doi.org/10.30953/bhty.v6.280 and https://doi.org/10.30953/bhty.v7.309 for background information. This session will cover changes over the year, and what’s next including:
∙ Macro parameters and regulations
∙ How the DLT area has evolved
∙ How other technology events have affected DLT
∙ How Web 3 is shaping up to be a merge of DLT, AI, and ZK
∙ What does this mean to global Healthcare?
11:45 AM — 12:30 PM | Patient-Centric Innovation in Decentralized Healthcare: The Importance of Including Patient Perspective Inclusion to Develop and Implement Health Data Technologies Arurag Banerjee, CEO and Co-founder, Quilt.AI
Munther Baara, VP, Product Strategy and Innovation, EDETEK, former Head of New Clinical Paradigms at Pfizer
Hui Huang, Co-Founder, Etheros HealthData Foundation, and Former Takeda Vice President, Head of Global Value & Access Oncology
Lisa Stewart — Principal, Torchlight, LLC
Patricia Waterous, Director of Delivery, Clinical Trials, Dimagi
Moderator: Tiffany Patrick, Founder and Principal Consultant, Health Advocacy Strategies and former Vice President, Patient Advocacy and Engagement, Alnylam Pharmaceuticals.
Key Discussion Points
∙ Patient Empowerment: How decentralized technologies empower patients in managing their health data and participating in their healthcare decisions.
∙ Benefits and Drawbacks: Analyze the pros and cons of using tokenization and blockchain from a patient’s viewpoint.
∙ Challenges and Solutions: Insight into addressing potential challenges patients face with decentralized technologies.
∙ Patient-Centric Innovation: Understanding the importance of integrating patient feedback in technology development for healthcare.
∙ Role of NGOs and Private Sector: Discuss the roles NGOs and private sector play in integrating patient-centric approaches within these technologies.
∙ Case Studies and Success Stories: Highlight real-world examples of patient engagement with decentralized health solutions to improve patient care.
∙ Collaboration Opportunities: Identify opportunities for engaging with NGOs and the private sector to foster patient-focused innovations.
∙ Future Trends: Explore upcoming trends and how they might further benefit patient engagement and healthcare outcomes.
Lunch: 12:30 PM — 1:30 PM
ConV2X Day 2 — PM Sessions Across Street
Qubic Labs | 1495 Hancock Street, 4th Floor, Quincy, MA 02169
1:30 PM — 2:30 PM | Learn How to Build, Assess, and Acquire Trusted Healthcare Solutions: Blockchain Maturity Model Assessment
Gerard Dache, President, Government Blockchain Association (GBA)
Organizations around the world are beginning to acquire blockchain solutions and need assistance with how to distinguish between a reliable solution and a hyped prototype. This tutorial demonstrates how the Blockchain Maturity Model (BMM), helps solution providers demonstrate credibility to potential customers as well as provide a roadmap to continuous improvement. Note: In some cases, the government can provide financial assistance to use the BMM to improve and demonstrate blockchain solutions. Learn more during this one hour session.
2:30 PM — 3:15 PM | Beyond the Hype: A Critical Look at AI, Blockchain & Cloud in Imaging Trials Dr. Olga Kubassova, President of Image Analysis Group, UK
Key Take-aways
∙ Wide-spread adoption of Artificial Intelligence (AI) to discover new drugs and improve existing ones will have significant impact on pharmaceutical drug development companies, their R&D strategies and planning of operational workflow for clinical trial execution.
∙ Modern data interoperability approaches and use of surrogate endpoints and companion biomarkers in trials today enable circular data flow and creation of company-wide knowledgebase systems, as the data gets discovered by translational teams, passes through clinical development and real-world-evidence, and then returns back to translational, powering new developments or optimizations of pharmaceutical assets.
∙ While A.I. remains to be a powerful tool for drug discovery, it is rapidly reshaping data value in real-world evidence studies, engagement with treating physicians and patients. It demands new standards for privacy, collection and retention of data.
∙ Rise of AI-driven biotech companies and powerful collaborations between pharma and tech players changes risk profiles and investment strategy for pharmaceutical R&D.
3:15 PM — 3:30 PM
Closing Remarks and Meeting Adjournment